Back to Search Start Over

A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.

Authors :
Choi JS
Kim CS
Park JW
Bae EH
Ma SK
Choi YD
Kim GH
Yoo HW
Kim SW
Source :
Renal failure [Ren Fail] 2012; Vol. 34 (3), pp. 390-3. Date of Electronic Publication: 2012 Jan 20.
Publication Year :
2012

Abstract

Fabry disease is a rare X-linked recessive glycosphingolipid storage disease that is caused by a deficiency of the lysosomal α-galactosidase A (GLA) enzyme, encoded by the GLA gene. This deficiency leads to the accumulation of glycosphingolipids throughout the body, which, in turn, causes multisystem diseases associated with renal, cardiovascular, and cerebrovascular complications. Recent molecular studies of GLA have demonstrated the existence of atypical variants in Fabry disease, suggesting significant genotype-phenotype correlations. In this study, we describe a renal variant of Fabry disease caused by a novel small insertion mutation in the GLA gene.

Details

Language :
English
ISSN :
1525-6049
Volume :
34
Issue :
3
Database :
MEDLINE
Journal :
Renal failure
Publication Type :
Academic Journal
Accession number :
22260214
Full Text :
https://doi.org/10.3109/0886022X.2011.647300